Search
for
Sort by
Research 61–90 of 120
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches
- Scalp melanoma: Distinctive high risk clinical and histological features
- Dermoscopy Research—An Update
- Anatomic location of primary melanoma: Survival differences and sun exposure
- Alopecia in Association with Malignancy: A Review
- Feline paraneoplastic alopecia associated with metastasising intestinal carcinoma
- Breast Cancer-Related Neoplastic Alopecia: A Case Report and Review of the Literature
- Congenital Combined Melanocytic Nevus of the Scalp With Associated Alopecia Areata
- Mechanism of PPARα agonist in alopecia areata
- Embryology, Histology, and Physiology of the Hair Follicle
- Perspectives on Dermatopathology
- Advances in dermatology research: A comprehensive literature review
- Mechanistic study of Erianin in alopecia areata
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Subject Index
- Clinical Management in Psychodermatology
- British Society for Dermatopathology: Summaries of Papers
- Oral cyclosporin does not arrest progression of androgenetic alopecia
- Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology
- Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease
- Malignant epithelial tumors: Part II. Therapy and prevention
- Multifocal Malignant Proliferating Trichilemmal Tumour: A Diagnostic Imitator Beyond the Scalp
- Malignant Melanoma and Its Stromal Nonimmune Microecosystem
- Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
- Angiosarcoma of the Scalp Mimicking an Inflammatory Scarring Alopecia and Diagnosed on Horizontal Histologic Sections
- Rare Case of Alopecia: Alopecia Neoplastica
- Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect
- Hair Repigmentation as a Melanoma Warning Sign
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors